Stock Symbol:

MNKD

Company Name:

MannKind Corporation

Company Description:

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

F-M-A-N

Stock Exchange:

NASDAQ

Predicted Split Price:

$27.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

3.4%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.